IPR & Legal

Australia strikes down AZ’s Crestor patents

The Federal Court of Australia has upheld a challenge to AstraZeneca’s patents for the cholesterol medication, Crestor (rosuvastatin). The company said that it is reviewing its legal options which could include filing an appeal.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

GSK in $3 billion settlement with the US

GlaxoSmithKline Plc said it has reached an agreement in principle with the US government to pay $3 billion to settle civil and criminal investigations relating to sales and marketing practices, including those for Avandia (rosiglitazone).

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

European court rules against stem cell patents in research

In a decision that will have far-reaching consequences for regenerative medicine, the European Court of Justice has ruled that inventions requiring the destruction of human embryos, or their prior use as base material, cannot be patented under European law if the purpose is purely for scientific research.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Luxembourg

ECJ to rule on stem cell patents

The European Court of Justice is scheduled to issue a judgment on 18 October 2011 in a case concerning the patentability of technology based on the use of human embryonic stem cells. The case involves a German researcher, Oliver Brüstle.

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Luxembourg

Actelion to make a $577 million provision against Asahi suit

Actelion Ltd, the Swiss specialist in treatments for pulmonary arterial hypertension (PAH), said it is making a provision of $577 million (CHF 485 million) for damages awarded by a jury in California.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland

Bavarian Nordic wins arbitration case against German research institution

Bavarian Nordic A/S announced that it has prevailed in a two-year-old arbitration case involving a German research institution regarding rights to the technology underpinning its vaccine portfolio.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Denmark

Conference Report: How Europe can do better in life science

It is something of a truism to say that money follows success. It is less easy to say why some companies are more successful than others, and how their successes can be repeated.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium

ECJ strikes down proposed patent court

The European Court of Justice (ECJ) has struck down a proposal from member states of the European Union to create a new, unified jurisdiction for the litigation of patent disputes saying the proposal is incompatible with the EU treaties.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium

Symphogen receives US patent on cancer compound

The US Patent and Trademark Office has awarded a patent to the privately-owned Symphogen A/S of Denmark for an oncology compound that is based on a mixture of two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Denmark

GSK raises investment in UK in response to tax measures

GlaxoSmithKline Plc has responded speedily to a new series of tax proposals from the UK government with a commitment to invest more than £500 million in manufacturing infrastructure in the country and to raise venture capital outlays.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom

Syndicate content